MYC and lymphoma: Possible confounding effects of IFNβ treatment and Cre recombinase induction were controlled by comparison with a phenotypically matched Eμ-Myc lymphoma cell line (30s) of the same genotype apart from the non-deletable Runx1wt/wt allele.